What is the best strategy for reducing deaths from heart disease?

Michael E Makover1, Shah Ebrahim

  • 1New York University School of Medicine, New York, New York, USA. mmakover@optonline.net

Plos Medicine
|April 21, 2005
PubMed

Insights

Two strategies combat coronary artery disease: targeting high-risk individuals or improving population-wide risk factors. Both aim to reduce global deaths from heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Epidemiology

Background:

  • Coronary artery disease (CAD) represents a significant global mortality burden.
  • Two primary strategies exist for CAD prevention: the "high risk" approach and the "population" approach.
  • The "high risk" strategy focuses on identifying and aggressively treating individuals with elevated risk factors, while the "population" strategy aims for broad shifts in risk factor distribution.

Purpose of the Study:

  • To debate the merits and methodologies of the "high risk" versus the "population" approach for coronary artery disease prevention.
  • To analyze the effectiveness of risk factor scoring and carotid ultrasound in identifying high-risk individuals.
  • To evaluate the potential of population-wide interventions in reducing the overall incidence of heart disease.

Main Methods:

  • Review of existing literature and epidemiological data on coronary artery disease.
  • Analysis of risk assessment tools, including risk factor scoring and carotid ultrasound.
  • Examination of public health strategies for modifying population-level risk factors for heart disease.

Main Results:

  • The "high risk" approach enables targeted, intensive interventions for those most likely to develop cardiovascular events.
  • The "population" approach seeks to reduce the average risk across all individuals, potentially preventing a larger number of events.
  • The optimal strategy likely involves a combination of both approaches, tailored to specific contexts and populations.

Conclusions:

  • Both the "high risk" and "population" strategies offer distinct pathways to reduce coronary artery disease mortality.
  • Effective CAD prevention requires a comprehensive understanding of risk factor distribution and intervention efficacy.
  • Further research is needed to optimize the integration of these strategies for maximum public health impact.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.9K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
642
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747